|
1
|
Oliveira LR, Castilho-Fernandes A,
Oliveira-Costa JP, et al:
CD44+/CD133+immunophenotype and matrix
metalloproteinase-9 influences on prognosis of early stage oral
squamous cell carcinoma patients. Head Neck. Nov 1–2013.(Epub ahead
of print). View Article : Google Scholar
|
|
2
|
Tanaka T, Tanaka M and Tanaka T: Oral
carcinogenesis and oral cancer chemoprevention: a review. Pathol
Res Int. 2011:4312462011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu HJ, Shin JA, Nam JS, et al: Apoptotic
effect of dibenzylideneacetone on oral cancer cells via modulation
of specificity protein 1 and Bax. Oral Dis. 19:767–774.
2012.PubMed/NCBI
|
|
4
|
Choi ES, Cho SD, Jeon JG, et al: The
apoptotic effect of the hexane extract of Rheum undulatum L.
in oral cancer cells through the down-regulation of specificity
protein 1 and survivin. Lab Anim Res. 27:19–24. 2011.PubMed/NCBI
|
|
5
|
Ariyawardana A and Ekanayake L: Screening
for oral cancer/pre-cancer: knowledge and opinions of dentists
employed in the public sector dental services of Sri Lanka. Asian
Pac J Cancer Prev. 9:615–618. 2008.PubMed/NCBI
|
|
6
|
Yeole BB, Ramanakumar AV and
Sankaranarayanan R: Survival from oral cancer in Mumbai (Bombay),
India. Cancer Causes Control. 14:945–952. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee HE, Choi ES, Shin JA, et al: Apoptotic
effect of methanol extract of Picrasma quassioides by regulating
specificity protein 1 in human cervical cancer cells. Cell Biochem
Funct. 32:229–235. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Firestone GL and Bjeldanes LF:
Indole-3-carbinol and 3-3′-diindolylmethane antiproliferative
signaling pathways control cell-cycle gene transcription in human
breast cancer cells by regulating promoter-Sp1 transcription factor
interactions. J Nutr. 133:S2448–S2455. 2003.
|
|
9
|
Jeon YJ, Ko SM, Cho JH, et al: The HDAC
inhibitor, panobinostat, induces apoptosis by suppressing the
expresssion of specificity protein 1 in oral squamous cell
carcinoma. Int J Mol Med. 32:860–866. 2013.PubMed/NCBI
|
|
10
|
Tsai JP, Hsiao PC, Yang SF, et al:
Licochalcone A suppresses migration and invasion of human
hepatocellular carcinoma cells through downregulation of MKK4/JNK
via NF-κB mediated urokinase plasminogen activator expression. PloS
One. 9:e865372014.PubMed/NCBI
|
|
11
|
Hao H, Hui W, Liu P, et al: Effect of
licochalcone A on growth and properties of Streptococcus
suis. PloS One. 8:e677282013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan X, Li D, Zhao H, et al: Licochalcone
A-induced human bladder cancer T24 cell apoptosis triggered by
mitochondria dysfunction and endoplasmic reticulum stress. Biomed
Res Int. 2013:4742722013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee CS, Kwak SW, Kim YJ, et al: Guanylate
cyclase activator YC-1 potentiates apoptotic effect of licochalcone
A on human epithelial ovarian carcinoma cells via activation of
death receptor and mitochondrial pathways. Eur J Pharmacol.
683:54–62. 2012. View Article : Google Scholar
|
|
14
|
Funakoshi-Tago M, Tanabe S, Tago K, et al:
Licochalcone A potently inhibits tumor necrosis factor
alpha-induced nuclear factor-kappaB activation through the direct
inhibition of IkappaB kinase complex activation. Mol Pharmacol.
76:745–753. 2009. View Article : Google Scholar
|
|
15
|
Fu Y, Hsieh TC, Guo J, et al:
Licochalcone-A, a novel flavonoid isolated from licorice root
(Glycyrrhiza glabra), causes G2 and late-G1 arrests in
androgen-independent PC-3 prostate cancer cells. Biochem Biophys
Res Commun. 322:263–270. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao XY, Hao M, Yang XY, et al:
Licochalcone A inhibits growth of gastric cancer cells by arresting
cell cycle progression and inducing apoptosis. Cancer Lett.
302:69–75. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoon G, Jung YD and Cheon SH: Cytotoxic
allyl retrochalcone from the roots of Glycyrrhiza inflata.
Chem Pharm Bull. 53:694–695. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu Y, Chen J, Li YJ, et al: Antioxidant
and anti-inflammatory activities of six flavonoids separated from
licorice. Food Chem. 141:1063–1071. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang SF, Chang CA, Lee DY, et al: Tumor
cell cycle arrest induced by shear stress: Roles of integrins and
Smad. Proc Natl Acad Sci USA. 105:3927–3932. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee KA, Lee SH, Lee YJ, et al: Hesperidin
induces apoptosis by inhibiting Sp1 and its regulatory protein in
MSTO-211H cells. Biomol Ther. 20:273–279. 2012. View Article : Google Scholar
|
|
21
|
Li L and Davie JR: The role of Sp1 and Sp3
in normal and cancer cell biology. Ann Anat. 192:275–283. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Willoughby JA Sr, Sundar SN, Cheung M, et
al: Artemisinin blocks prostate cancer growth and cell cycle
progression by disrupting Sp1 interactions with the
cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene
expression. J Biol Chem. 284:2203–2213. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim DW, Ko SM, Jeon YJ, et al:
Anti-proliferative effect of honokiol in oral squamous cancer
through the regulation of specificity protein 1. Int J Oncol.
43:1103–1110. 2013.PubMed/NCBI
|
|
24
|
Deniaud E, Baguet J, Mathieu AL, et al:
Overexpression of Sp1 transcription factor induces apoptosis.
Oncogene. 25:7096–7105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jutooru I, Chadalapaka G, Sreevalsan S, et
al: Arsenic trioxide downregulates specificity protein (Sp)
transcription factors and inhibits bladder cancer cell and tumor
growth. Exp Cell Res. 316:2174–2188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shin JA, Kim JJ, Choi ES, et al: In vitro
apoptotic effects of methanol extracts of Dianthus chinensis
and Acalypha australis L. targeting
specificity protein 1 in human oral cancer cells. Head Neck.
35:992–998. 2012.PubMed/NCBI
|
|
27
|
Park HG, Bak EJ, Woo GH, et al:
Licochalcone E has an antidiabetic effect. J Nutr Biochem.
23:759–767. 2012. View Article : Google Scholar
|
|
28
|
Chiefari E, Brunetti A, Arturi F, et al:
Increased expression of AP2 and Sp1 transcription factors in human
thyroid tumors: a role in NIS expression regulation? BMC Cancer.
2:352002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hosoi Y, Watanabe T, Nakagawa K, et al:
Upregulation of DNA-dependent protein kinase activity and Sp1 in
colorectal cancer. Int J Oncol. 25:461–468. 2004.PubMed/NCBI
|
|
30
|
Yao JC, Wang L, Wei D, et al: Association
between expression of transcription factor Sp1 and increased
vascular endothelial growth factor expression, advanced stage, and
poor survival in patients with resected gastric cancer. Clin Cancer
Res. 10:4109–4117. 2004. View Article : Google Scholar
|
|
31
|
Chu S and Ferro TJ: Sp1: regulation of
gene expression by phosphorylation. Gene. 348:1–11. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deniaud E, Baguet J, Chalard R, et al:
Overexpression of transcription factor Sp1 leads to gene expression
perturbations and cell cycle inhibition. PLoS One. 4:e70352009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Blume SW, Snyder RC, Ray R, et al:
Mithramycin inhibits SP1 binding and selectively inhibits
transcriptional activity of the dihydrofolate reductase gene in
vitro and in vivo. J Clin Invest. 88:1613–1621. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pietrzak M and Puzianowska-Kuznicka M:
p53-dependent repression of the human MCL-1 gene encoding an
anti-apoptotic member of the BCL-2 family: the role of Sp1 and of
basic transcription factor binding sites in the MCL-1 promoter.
Biol Chem. 389:383–393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi KH, Shim JH, Huong LD, et al:
Inhibition of myeloid cell leukemia-1 by tolfenamic acid induces
apoptosis in mucoepidermoid carcinoma. Oral Dis. 17:469–475. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li F and Altieri DC: Transcriptional
analysis of human survivin gene expression. Biochem J. 344(Pt 2):
305–311. 1999. View Article : Google Scholar
|
|
37
|
Li Y, Xie M, Yang J, et al: The expression
of antiapoptotic protein survivin is transcriptionally upregulated
by DEC1 primarily through multiple sp1 binding sites in the
proximal promoter. Oncogene. 25:3296–3306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sherr CJ and Roberts JM: CDK inhibitors:
positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Murray AW: Recycling the cell cycle:
cyclins revisited. Cell. 116:221–234. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weinstein IB: Relevance of cyclin D1 and
other molecular markers to cancer chemoprevention. J Cell Biochem
(Suppl). 25:23–28. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Alao JP: The regulation of cyclin D1
degradation: roles in cancer development and the potential for
therapeutic invention. Mol Cancer. 6:242007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Akgul C: Mcl-1 is a potential therapeutic
target in multiple types of cancer. Cell Mol Life Sci.
66:1326–1336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Andersson Y, Juell S and Fodstad O:
Downregulation of the antiapoptotic MCL-1 protein and apoptosis in
MA-11 breast cancer cells induced by an anti-epidermal growth
factor receptor - Pseudomonas exotoxin a immunotoxin. Int J Cancer.
112:475–483. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chun JY, Hu Y, Pinder E, et al: Selenium
inhibition of survivin expression by preventing Sp1 binding to its
promoter. Mol Cancer Ther. 6:2572–2580. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun Y, Giacalone NJ and Lu B: Terameprocol
(tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of
Sp1-mediated survivin transcription, induces radiosensitization in
non-small cell lung carcinoma. J Thorac Oncol. 6:8–14. 2011.
View Article : Google Scholar : PubMed/NCBI
|
